BioAge Labs, Inc. Contracts & Agreements
19 Contracts & Agreements
- Business Finance (8 contracts)
- Human Resources (3)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (5)
- Office and Laboratory Lease by and between the Company and ES East, LLC, dated August 23, 2024 (Filed With SEC on November 7, 2024)
- Share Purchase Agreement, by and among the Company and the Purchaser (Filed With SEC on September 27, 2024)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2024)
- Form of Indemnity Agreement (Filed With SEC on September 18, 2024)
- 2024 Equity Incentive Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 18, 2024)
- 2024 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 18, 2024)
- Change in Control and Severance Plan (Filed With SEC on September 18, 2024)
- Offer Letter by and between the Registrant and Kristen Fortney, dated September 17, 2024 (Filed With SEC on September 18, 2024)
- Offer Letter by and between the Registrant and Eric Morgen, dated September 17, 2024 (Filed With SEC on September 18, 2024)
- Offer Letter by and between the Registrant and Paul Rubin, dated September 17, 2024 (Filed With SEC on September 18, 2024)
- Form of Common Stock Certificate (Filed With SEC on September 3, 2024)
- Warrant to Purchase Common Stock, dated July 31, 2018, by and among the Registrant and Silicon Valley Bank (Filed With SEC on September 3, 2024)
- Form of 2022 Warrant to Purchase Common Stock (Filed With SEC on September 3, 2024)
- Amended and Restated Investors Rights Agreement, dated February 1, 2024, by and among the Registrant and certain of its stockholders (Filed With SEC on September 3, 2024)
- 2015 Equity Incentive Plan, as amended, and forms of award agreements (Filed With SEC on September 3, 2024)
- Lease Agreement, by and between the Registrant and Erickson Properties LLC dated August 3, 2017, as amended (Filed With SEC on September 3, 2024)
- Exclusive License Agreement by and between the Registrant and Amgen Inc. dated April 5, 2021, as amended (Filed With SEC on September 3, 2024)
- Material Transfer Agreement by and between the Registrant and Eli Lilly and Company dated October 25, 2023 (Filed With SEC on September 3, 2024)
- Loan and Security Agreement, dated July 31, 2018, by and among the Registrant and Silicon Valley Bank (Filed With SEC on September 3, 2024)
